IP Library Granted Patent US 8,765,408
Granted Patent B2
US 8,765,408 · App. 13/363,848 · Granted Jul 1, 2014

Prophage element-free bacteria

Inventors: Frederick R. Blattner (Madison, WI); John W. Campbell (Oak Park, IL); David Frisch (Fitchburg, WI); Guy Plunkett, III (Madison, WI); Gyorgy Posfai (Szeged, HU)
Assignee: Wisconsin Alumni Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,765,408
App. No.
13/363,848
Granted
Jul 1, 2014
Kind
B2
Abstract

The present invention provides a bacterium having a genome that is genetically engineered to be smaller than the genome of its native parent strain. A bacterium with a smaller genome can produce a commercial product more efficiently. The present invention also provides methods for deleting genes and other DNA sequences from a bacterial genome. The methods provide precise deletions and seldom introduces mutations to the genomic DNA sequences around the deletion sites. Thus, the methods can be used to generate a series of deletions in a bacterium without increasing the possibility of undesired homologous recombination within the genome. In addition, some of the methods provided by the present invention can also be used for replacing a region of a bacterial genome with a desired DNA sequence.

Claims (11)

1. A non-naturally occurring Escherichia coli ( E. coli ) bacterium having a genome between 4.41 Mb and 2.78 Mb and lacking CP4-6, DLP12, λ*B, RybB*B, e14, Rac, Qin, CP4-44, PR-X, KpLE1, CPZ-55, CP4-57, PheV*B, SelC*B, and KpLE2 prophage elements.

2. The bacterium of claim 1 , wherein the bacterium additionally lacks all IS1, IS2, IS3, IS5, IS150 and IS186 insertion sequences.

3. The bacterium of claim 1 , wherein the parent strain of said bacterium is a K12 or B strain.

4. The bacterium of claim 3 , wherein the parent strain of said bacterium is K12 strain MG1655.

5. The bacterium of claim 3 , wherein the parent strain of said bacterium is B strain BL21(DE3).

6. The bacterium of claim 1 , wherein the bacterium comprises a vector.

7. The bacterium of claim 6 , wherein the vector comprises a nucleic acid encoding a polypeptide and wherein the nucleic acid is operatively linked to an expression control sequence.

8. The bacterium of claim 7 , wherein the vector is a plasmid.

9. A method of producing a polypeptide comprising culturing a bacterium according to claim 7 under suitable conditions to allow expression of the polypeptide and collecting the polypeptide.

10. The bacterium of claim 4 , wherein the genome of the bacterium is lacking at least the nucleic sequences set forth in Table 1.

11. The bacterium of claim 1 , wherein the chromosome of the bacterium does not comprise scars.

Assignments (4)
CONFIRMATORY LICENSE Recorded Oct 1, 2014
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 033869/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2012
From: CAMPBELL, JOHN W.
To: SCARAB GENOMICS LLC
Reel/Frame 028408/0511 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2012
From: SCARAB GENOMICS LLC
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 028408/0573 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2012
From: BLATTNER, FREDERICK; PLUNKETT, GUY, III; FRISCH, DAVID; POSFAI, GYORGY
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 028192/0652 →
Continuity (8)
Continuation In Part 11400711 · Apr 7, 2006
Continuation In Part 11275094 · Dec 9, 2005
Continuation In Part 10896739 · Jul 22, 2004
Continuation PCTUS0301800 · Jan 22, 2003
Continuation In Part 10057582 · Jan 23, 2002
Provisional Application 60634611 · Dec 9, 2004
Provisional Application 60409089 · Sep 6, 2002
Related Publication 20120219994A1 · Aug 30, 2012